In contrast, CDKN1B and CDKN1C are cyclin-dependent kinase (CDK) inhibitors, p27Kip1 and p57Kip2 respectively, that usually act as tumor suppressors, but their regulation is altered during tumor processes, leading to unchecked cellular proliferation [45]. Here, CDKN1B is linked to neoplasm.